These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11082110)

  • 41. Mechanism of GABA receptor-mediated inhibition of spontaneous GABA release onto cerebellar Purkinje cells.
    Harvey VL; Stephens GJ
    Eur J Neurosci; 2004 Aug; 20(3):684-700. PubMed ID: 15255979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911.
    Pibiri F; Carboni G; Carai MA; Gessa GL; Castelli MP
    Eur J Pharmacol; 2005 May; 515(1-3):94-8. PubMed ID: 15893746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The GABA B receptor antagonists CGP35348 and CGP52432 inhibit glycine exocytosis: study with GABA B1- and GABA B2-deficient mice.
    Romei C; Luccini E; Raiteri M; Raiteri L
    Pharmacol Res; 2010 Jun; 61(6):547-52. PubMed ID: 20138995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling.
    Calver AR; Robbins MJ; Cosio C; Rice SQ; Babbs AJ; Hirst WD; Boyfield I; Wood MD; Russell RB; Price GW; Couve A; Moss SJ; Pangalos MN
    J Neurosci; 2001 Feb; 21(4):1203-10. PubMed ID: 11160390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agonist-induced desensitization and endocytosis of heterodimeric GABAB receptors in CHO-K1 cells.
    González-Maeso J; Wise A; Green A; Koenig JA
    Eur J Pharmacol; 2003 Nov; 481(1):15-23. PubMed ID: 14637170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretreatment of rat brain synaptosomes with GABA increases subsequent GABA uptake via GABA(B) receptor activation.
    Cupello A; Scarrone S
    Neurochem Res; 2001 Jan; 26(1):11-4. PubMed ID: 11358276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 2-hydroxy-saclofen, an antagonist of GABAB action, upon the binding of baclofen and other receptor ligands in rat cerebrum.
    al-Dahan MI; Tehrani MH; Thalmann RH
    Brain Res; 1990 Sep; 526(2):308-12. PubMed ID: 2175242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant GABA(B) receptors formed from GABA(B1) and GABA(B2) subunits selectively inhibit N-type Ca(2+) channels in NG108-15 cells.
    Easter A; Spruce AE
    Eur J Pharmacol; 2002 Apr; 440(1):17-25. PubMed ID: 11959084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GABAB receptors.
    Kerr DI; Ong J
    Pharmacol Ther; 1995; 67(2):187-246. PubMed ID: 7494864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
    Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
    Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of the nanomolar photoaffinity GABA(B) receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA(B) receptor forms.
    Belley M; Sullivan R; Reeves A; Evans J; O'Neill G; Ng GY
    Bioorg Med Chem; 1999 Dec; 7(12):2697-704. PubMed ID: 10658574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of GABA(B) receptors involved in inhibition of motility associated with acetylcholine release in the dog small intestine: possible existence of a heterodimer of GABA(B1) and GABA(B2) subunits.
    Kawakami S; Uezono Y; Makimoto N; Enjoji A; Kaibara M; Kanematsu T; Taniyama K
    J Pharmacol Sci; 2004 Apr; 94(4):368-75. PubMed ID: 15107576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors.
    Lingenhoehl K; Brom R; Heid J; Beck P; Froestl W; Kaupmann K; Bettler B; Mosbacher J
    Neuropharmacology; 1999 Nov; 38(11):1667-73. PubMed ID: 10587082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor.
    Binet V; Brajon C; Le Corre L; Acher F; Pin JP; Prézeau L
    J Biol Chem; 2004 Jul; 279(28):29085-91. PubMed ID: 15126507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The heteromeric GABA-B receptor recognizes G-protein alpha subunit C-termini.
    Franek M; Pagano A; Kaupmann K; Bettler B; Pin JP; Blahos J
    Neuropharmacology; 1999 Nov; 38(11):1657-66. PubMed ID: 10587081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of calcium current by recombinant GABA(B) receptors.
    Easter A; Spruce AE
    Neuroreport; 2000 Nov; 11(16):3431-4. PubMed ID: 11095493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GABAB receptor complex as a potential target for tumor therapy.
    Jiang X; Su L; Zhang Q; He C; Zhang Z; Yi P; Liu J
    J Histochem Cytochem; 2012 Apr; 60(4):269-79. PubMed ID: 22266766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of subtypes of gamma-aminobutyric acid receptors in an Ascaris muscle preparation by binding assay and binding of PF1022A, a new anthelmintic, on the receptors.
    Chen W; Terada M; Cheng JT
    Parasitol Res; 1996; 82(2):97-101. PubMed ID: 8825201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors.
    Urwyler S; Gjoni T; Kaupmann K; Pozza MF; Mosbacher J
    Eur J Pharmacol; 2004 Jan; 483(2-3):147-53. PubMed ID: 14729102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the minimal functional ligand-binding domain of the GABAB1b receptor.
    Deriu D; Gassmann M; Firbank S; Ristig D; Lampert C; Mosbacher J; Froestl W; Kaupmann K; Bettler B; Grütter MG
    Biochem J; 2005 Mar; 386(Pt 3):423-31. PubMed ID: 15482257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.